Selinexor Combined With Induction Chemotherapy for Children With NUP98-positive AML
Selinexor Combined With Induction Chemotherapy for Children With NUP98-positive AML
Active, not recruiting · NCT07437170 · Registry updated 2026-02-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Selinexor Combined With Induction Chemotherapy for Children With NUP98-positive AML | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, childhood acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Active, not recruiting | Phase 2 | 2026-02-27 | NCT07437170 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Children's Hospital, Zhejiang University School of Medicine | Hangzhou | China | 3 |